Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
Authors
Keywords
Epidemiology, Incidence, Prevalence, Primary Sclerosing Cholangitis
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-30
DOI
10.1016/j.cgh.2021.08.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The epidemiology of UK autoimmune liver disease varies with geographic latitude
- (2021) Gwilym J. Webb et al. Clinical Gastroenterology and Hepatology
- Increased risk of cancer in patients with primary sclerosing cholangitis
- (2021) Aiva Lundberg Båve et al. Hepatology International
- Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status
- (2021) Vijay S. Are et al. LIVER INTERNATIONAL
- An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort
- (2020) Zeinab Bakhshi et al. JOURNAL OF GASTROENTEROLOGY
- Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland
- (2020) Nina Barner-Rasmussen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study
- (2020) Ola Olén et al. Lancet Gastroenterology & Hepatology
- Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age
- (2020) Palak J. Trivedi et al. GASTROENTEROLOGY
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy
- (2020) Marco Carbone et al. International Journal of Environmental Research and Public Health
- Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis
- (2020) Mehul Lamba et al. Clinical Gastroenterology and Hepatology
- Projection of liver transplant activity per indication in France and United Kingdom
- (2020) Mark Connolly et al. JOURNAL OF HEPATOLOGY
- Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis
- (2020) Emma L Culver et al. LIVER INTERNATIONAL
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
- (2019) James A King et al. Lancet Gastroenterology & Hepatology
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Sudabeh Alatab et al. Lancet Gastroenterology & Hepatology
- Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
- (2017) Lars Aabakken et al. ENDOSCOPY
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
- (2017) Tobias J. Weismüller et al. GASTROENTEROLOGY
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis
- (2017) Palak J. Trivedi et al. JOURNAL OF HEPATOLOGY
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom
- (2017) Huifang Liang et al. MEDICINE
- Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
- (2016) Aida Kapic Lunder et al. GASTROENTEROLOGY
- ACG Clinical Guideline: Primary Sclerosing Cholangitis
- (2015) Keith D Lindor et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Liver transplantation in the Nordic countries – An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013
- (2015) Bjarte Fosby et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
- (2012) Kirsten Boonstra et al. JOURNAL OF HEPATOLOGY
- The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population
- (2011) Elaine Toy et al. BMC GASTROENTEROLOGY
- Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden
- (2010) Björn Lindkvist et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study
- (2008) Tim R. Card et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started